IDNA 股價展望與 ETF 分析 - 配息·管理費·持股·NAV·RSI·MACD

IDNA

iShares Genomics Immunology and Healthcare ETF

收盤價 10月30日 4:00 PM ET（韓國 10/31 05:00）

$42.76

-0.23 ▼ -0.54%

10月30日 4:00 PM ET（韓國 10/31 05:00）

$42.76

+0.00 +0.00%

上升楔形阻力線 45.01 支撐線 41.86 維持由 AI 繪製的參考線，可能有誤，僅供參考，並非預測。

詳細指標表

Category ⓘ	Global or ExUS Equities - Industry Sector	Expense ⓘ	0.47%	Return% 1Y ⓘ	71.26%	Total Holdings ⓘ	63	Perf Week ⓘ	4.52%	Volume ⓘ	291,126
Asset Type ⓘ	Equities (Stocks)	AUM ⓘ	$338M	Return% 3Y ⓘ	34.63%	NAV ⓘ	$43.05	Perf Month ⓘ	2.69%	Avg Volume ⓘ	0.14M
ETF Type ⓘ	Global Equities	Dividend TTM ⓘ	$0.28 (0.65%)	Return% 5Y ⓘ	-1.94%	52W High ⓘ	-2.35%	Perf Quarter ⓘ	31.89%	Rel Volume ⓘ	2.09
Active/Passive ⓘ	Passive	Div Gr. 3/5Y ⓘ	31.32% 20.75%	Return% 10Y ⓘ	-	52W Low ⓘ	76.04%	Perf Half Y ⓘ	45.84%	Prev Close ⓘ	$42.99
IPO ⓘ	2019/6/13	Flows% 1M ⓘ	10.86%	Return% SI ⓘ	8.54%	RSI (14) ⓘ	56.91	Perf YTD ⓘ	63.27%	Price ⓘ	$42.76
Beta ⓘ	0.97	Flows% 3M ⓘ	30.25%	Flows% YTD ⓘ	46.38%	Flows% 1Y ⓘ	45.62%	Perf Year ⓘ	69.62%	Volatility(W/M) ⓘ	3.38% 3.28%
SMA20 ⓘ	2.59%	SMA50 ⓘ	4.76%	SMA200 ⓘ	28.65%	ATR ⓘ	1.3

ETF 簡介

iShares Genomics Immunology and Healthcare ETFIDNA | NYSE | 醫療類股查看深度分析

iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma IndexTM. The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.

IDNA ETF 一覽

0.47% 越低越好

$338M 管理資產

63檔

0.65% 半年配

掛牌日 2019年

管理方式追蹤指數

發行公司 iShares (BlackRock)

主要持有標的持有 63 檔

前 10 大持股占 基金的 49%